-
1Academic Journal
المؤلفون: N Toroptsova V, O Nikitinskaya A, T Korotkova A, N Demin V, A Smirnov V, L Benevolenskaya I, L Rozinskaya Y, S. Rodionova S., Н. Торопцова В., О. Никитинская А., Т. Короткова А., А. Смирнов В., Л. Беневоленмкая И.
المصدر: Rheumatology Science and Practice; Vol 46, No 3 (2008); 23-29 ; Научно-практическая ревматология; Vol 46, No 3 (2008); 23-29 ; 1995-4492 ; 1995-4484 ; 10.14412/1995-4484-2008-3
مصطلحات موضوعية: osteoporosis, treatment, strontium ranelate, остеопороз, лечение, стронция ранелат
وصف الملف: application/pdf
Relation: https://rsp.mediar-press.net/rsp/article/view/792/484; Arnaud C.D., Zanchetta J. R. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. New Eng. J. Med., 2001, 344, 1434-1441. Black D.M., Cummings S.R., Karpf D.B. et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebra! fractures. Lancet, 1996, 348, 1535-1541. Boivin G.Y., Chavassieux P.M., Sandora A.C. et al. Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women. Bone, 2000, 27, 687-694. Bruyere O., Delmas P.D., Devogelaer J-P. et al. Relations between increase in femoral neck bone mineral density and decrease in hip fracture incidence during treatment with strontium ranelate. Osteoporosis Int., 2006, 17(suppl. 1), 96.Abstr. 6th Europ. Congr. on Clin, and Econom. Aspects Osteopor. and Osteoarthr. - ECCEO 6, 15-18 March 2006, Vienna, Austria. Bruyere O., Roux C., Cannata J.B., et al. Associations between increase in bone mineral density and decrease in clinical vertebral fracture incidence during a treatment with strontium ranelate. Osteoporosis Int., 2006, 17, (suppl. 1.), 8. Buechler J., Chappuis P., Saffar J.L. et al. Strontium ranelate inhibits bone resorption while maintaining bone formation in alveolar bone in monkeys (Macaca fascicularis). Bone, 2001, 29, 176-179. Chavassieux P.M., Arlot M.E., Red a C. et al. Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis. J. Clin. Investig., 1997, 100, 1475-1480. Ettinger B., Black D.M. , Mitlak B.H. et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treatment with raloxifene: results from a 3-year randomized clinical trial. JAMA, 1999, 282, 637-645. Merie P.J. Optimizing bone metabolism in osteoporosis: insight into the pharmacologic profile of strontium ranelate. Osteoporosis Int., 2003, 14, S9-S12. Meunier P.J., Slosman D.O., Delmas P.D. et al. Stivntium ranelate: dose-dependent effects in established postmenopausal vertebral osteoporosis — a 2 — year randomized placebo controlled trial. J. Clin. Endocrinol. Metabol., 2002, 87, 2060-2066. Meunier P.J., Roux C., Seeman E. et al. The effects of strontium Ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. New Engl. J. Med., 2004, 350, 459-468. Meunier P.J., Arlot M.E., Roux C. et al. How to rebalance bone turnover in favor offormation. Osteoporosis Int., 2006, 17(suppl. I), 114. Register JY, Meunier PJ. Strontium ranelate phase 2 dose-ranging studies: PREVOS and STRATOS studies. Osteoporosis Int., 2003, 14. (suppl. 3), S56-S65. Register J. Y., Seeman E., De Vernejout M.C. et al. Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis treatment of peripheral osteoporosis (TROPOS) study. J. Clin. Endocrin. Metabol., 2005, 90, 2816-2822. Register J. Y., Sarlet N. Lejeune E. et al. Stivntium ranelate: a new treatment for postmenopausal osteoporosis with a dual mode of action. J. Curr. Osteoporosis Rep., 2005, 1, 30-34. RouxC., Register J. Y, Fechtenbaum J. etal. Vertebral fracture risk reduction with strontium ranelate in women with postmenopausal osteoporosis is independent of baseline risk factors. J. Bone Miner. Res., 2006, Online published January, 22. Seeman E. Pathogenesis of bone fragility in women and men. Lancet, 2002, 359, 1841-1850.; https://rsp.mediar-press.net/rsp/article/view/792